One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1002/14651858.cd011230.pub2
Copy DOI Publication Date: Sep 15, 2014 | |
 Citations: 157 |
Affiliation: Zimmer Biomet (Netherlands), University Medical Center Freiburg, Cleveland Clinic, University of Bristol, Queen's University Belfast, Klinikum Bremen-Mitte, Bloomberg (United States), Provincia Autonoma di Trento, Johns Hopkins University, University of Modena and Reggio Emilia, California University of Pennsylvania, Hôpital de la Croix-Rousse, University of Florence, University of Milan, Istituti di Ricovero e Cura a Carattere Scientifico, Mario Negri Institute for Pharmacological Research, Boston University, University School, University of East AngliaSystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
